Investors
Information Disclosure
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.05.29
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.05.25
-
VOLUNTARY ANNOUNCEMENT2023.05.23
-
DOCUMENTS ON DISPLAY - SHARE OPTION SCHEME2023.05.17
-
VOLUNTARY ANNOUNCEMENT - INNOVATIVE MEDICINE “F-627 (EFBEMALENOGRASTIM ALFA INJECTION)” APPROVED FOR MARKETING2023.05.09
-
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 20232023.05.05
-
2022 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT2023.04.28
-
2022 ANNUAL REPORT2023.04.28